Fresenius Medical Care Appoints Helen Giza as Chief Executive Officer

Helen Giza, 54, has been appointed as the Chief Executive Officer of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases. With immediate effect, Helen Giza will lead the company in sharpening its focus on operational turnaround, driving performance improvements, and focusing on its core. She previously served as Deputy CEO and Chief Financial Officer of Fresenius Medical Care, gaining thorough expertise in renal healthcare and deep understanding of the company. Helen Giza will continue to serve as Chief Financial Officer until a successor is appointed for this position.

Key Takeaways:

Helen Giza has been appointed as the Chief Executive Officer of Fresenius Medical Care, succeeding Dr. Carla Kriwet, who has resigned due to strategic differences.
Helen Giza has been serving as Deputy CEO and Chief Financial Officer of Fresenius Medical Care since 2022, heading the FME25 transformation program.
The Supervisory Board of Fresenius Medical Care Management AG has unanimously appointed Helen Giza to succeed Dr. Carla Kriwet.
Helen Giza will continue to serve as Chief Financial Officer until a successor is appointed for this position, at which time she will assume the role of CEO.
The company operates 4,153 dialysis clinics worldwide, providing dialysis treatments for approximately 345,000 patients globally.
Helen Giza's experience includes roles at Takeda Pharmaceuticals, TAP Pharmaceuticals, and Abbott Laboratories, with expertise in renal healthcare and deep understanding of the company.
Helen Giza holds a Master of Business Administration from the Kellogg School of Management at Northwestern University in Evanston, Illinois, USA.

Statistics:

3.8 million patients worldwide regularly undergo dialysis treatment.
Approximately 345,000 patients around the globe receive dialysis treatments using Fresenius Medical Care's products and services.
The company's network of 4,153 dialysis clinics provides treatment to patients worldwide.

Sources:

Fresenius Medical Care
Source: Fresenius Medical Care [Category: Healthcare, Management Changes]